If you are in crisis, help is available now. Call or text 988 to reach the Suicide & Crisis Lifeline, or text HOME to 741741. If someone is in immediate danger, call 911. This site is information only and cannot provide urgent help.

ketaminepennsylvania.com
Menu

Is Ketamine Therapy Legal in Pennsylvania?

Yes. Ketamine is a federal Schedule III controlled substance, and physicians licensed in Pennsylvania may prescribe and administer it — including off-label for depression, which means for a purpose the FDA has not formally approved.

The federal baseline

Ketamine and its mirror-image form esketamine are Schedule III controlled substances under federal law, which means they have accepted medical uses but can be misused. as of 18 Jul 2026 · U.S. Drug Enforcement Administration (source 1, opens in a new tab)Esketamine has no separate DEA listing; it is covered as an enantiomer of ketamine, and the Spravato label carries the CIII designation.

Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)

The FDA approved Spravato (esketamine) nasal spray on 5 March 2019, for use with an oral antidepressant, for adults with treatment-resistant depression. as of 5 Mar 2019 · U.S. Food and Drug Administration (source 4, opens in a new tab)

Spravato is available only through a restricted safety programme called a Risk Evaluation and Mitigation Strategy (REMS), and may only be given in a certified healthcare setting under a provider's direct observation. Patients never take it home. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 5, opens in a new tab)

Pennsylvania law: who may give it

In Pennsylvania, medical doctors and osteopathic physicians may prescribe and administer ketamine. A certified registered nurse practitioner may prescribe it — up to a 90-day supply — only under a written collaborative agreement with a physician, and only if it falls within the speciality that agreement covers. Pennsylvania has not adopted full practice authority for nurse practitioners. A physician assistant may prescribe it under a written agreement with a supervising physician. as of 18 Jul 2026 · Pennsylvania Code and Bulletin (source 4, opens in a new tab)The physician assistant rule cited is the State Board of Medicine's. Physician assistants supervised by an osteopathic physician fall under a separate parallel rule that we have not separately checked.

Who may own a clinic in Pennsylvania

Pennsylvania has no single statute banning corporate ownership of medical practices, but a long-standing court doctrine bars businesses without a medical licence from controlling clinical decisions, and Pennsylvania courts have struck down management agreements that gave non-physician managers too much control or too large a share of profits. as of 18 Jul 2026 · Pennsylvania Code and Bulletin (source 1, opens in a new tab)The doctrine rests on case law rather than a single statute, which makes it harder to cite precisely than an explicit prohibition would be.

This matters to you only indirectly, but it shapes which clinics exist here and how they are structured.

Pennsylvania Prescription Drug Monitoring Program (PA PDMP)

Prescription monitoring is where published information about ketamine most often goes wrong, because three different questions get collapsed into one. They have different answers.

What must be reported

Pennsylvania's Prescription Drug Monitoring Program was created by the ABC-MAP Act of 2014. Pharmacies and dispensing practitioners must report every Schedule II through Schedule V controlled substance they dispense, by the close of the next business day. as of 1 Jan 2017 · Pennsylvania Department of Health (source 4, opens in a new tab)The deadline is the close of the next business day, not 24 hours — across a weekend that is materially longer. Older material calls this system 'AWARxE', which is the former platform vendor's name; the Department of Health no longer uses it.

When a prescriber must check

A Pennsylvania prescriber must check the monitoring system in three situations: the first time they prescribe any controlled substance to a patient, whenever they have reason to believe a patient may be misusing or diverting drugs, and every single time they prescribe an opioid or a benzodiazepine. as of 1 Jan 2017 · Pennsylvania General Assembly (source 4, opens in a new tab)The Department of Health separately recommends checking before every controlled substance prescription as good practice. That is advice, not the legal trigger, and the two should not be confused.

Does this apply to ketamine?

Partly. Because ketamine is neither an opioid nor a benzodiazepine, a Pennsylvania prescriber is not required to check the monitoring system every time they prescribe it — only on the first controlled substance they prescribe you, or if they suspect misuse. Separately, ketamine and Spravato given to you inside a clinic are generally not recorded at all, because the law only covers medicine dispensed for you to take away. as of 18 Jul 2026 · Pennsylvania Department of Health (source 4, opens in a new tab)Take-home sublingual ketamine dispensed by a pharmacy is recorded. In-clinic infusions and Spravato generally are not.

Telehealth

Pennsylvania is one of the stricter states here. A State Board of Medicine licensee must carry out an initial in-person physical examination before prescribing a controlled substance, apart from emergencies. A narrow telehealth exception added in December 2024 covers only buprenorphine and methadone in narcotic treatment programmes — it does not cover ketamine. In practice this means your first appointment cannot be done entirely remotely. as of 21 Dec 2024 · Pennsylvania Code and Bulletin (source 8, opens in a new tab)Federal DEA telemedicine flexibilities run separately and expire at the end of 2026, but they do not override a stricter state rule. We have not separately checked the parallel osteopathic board rule.

Through 31 December 2026, clinicians registered with the DEA may prescribe controlled medicines such as ketamine after a video telemedicine visit, without an in-person examination first. as of 1 Jan 2026 · Drug Enforcement Administration (source 1, opens in a new tab)This is the fourth temporary extension. Each of the previous three was issued close to its expiry date, so the position may change late in 2026.

The DEA's proposed rule to create a special registration for prescribing controlled medicines by telemedicine, published on 17 January 2025, is still only a proposal and has not been finalised. as of 17 Jan 2025 · Drug Enforcement Administration (source 1, opens in a new tab)No final rule and no withdrawal notice has been published. A rule can also be shelved without a formal withdrawal, so this should not be read as a statement that the DEA intends to finalise it.

Two things are worth holding onto here. The federal flexibility has a hard end date and has been extended four times at short notice, so anything you read about telehealth ketamine access needs a date attached to it. And a stricter state rule still applies regardless of what federal law permits.

Spravato is a separate case entirely: it must be taken in a certified clinic under observation, so it cannot be prescribed for home use whatever the telehealth position is.

How to check a clinician before you book

  1. Go to the Pennsylvania State Board of Medicine licence lookup.
  2. Search by name, and confirm the licence is current and unrestricted.
  3. Look for disciplinary history. It is published for a reason, and it is the single most useful thing you can check in five minutes.
  4. If you are seeking Spravato specifically, confirm the clinic is REMS-certified using the official locator . No other directory, including ours, can tell you that.